A detailed history of Northern Trust Corp transactions in Kempharm, Inc stock. As of the latest transaction made, Northern Trust Corp holds 354,720 shares of KMPH stock, worth $1.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
354,720
Previous 293,300 20.94%
Holding current value
$1.75 Million
Previous $1.45 Million 20.99%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
N/A
61,420 Added 20.94%
354,720 $1.75 Million
Q2 2024

Aug 14, 2024

SELL
N/A
-3,767 Reduced 1.27%
293,300 $1.45 Million
Q1 2024

May 14, 2024

SELL
N/A
-3,999 Reduced 1.33%
297,067 $1.47 Million
Q4 2023

Feb 13, 2024

BUY
N/A
30,624 Added 11.32%
301,066 $1.49 Million
Q3 2023

Nov 13, 2023

SELL
N/A
-1,701 Reduced 0.63%
270,442 $1.34 Million
Q2 2023

Aug 11, 2023

BUY
$4.94 - $6.29 $1.07 Million - $1.36 Million
216,435 Added 388.52%
272,143 $1.34 Million
Q1 2023

May 15, 2023

BUY
$4.13 - $6.27 $12,047 - $18,289
2,917 Added 5.53%
55,708 $306,000
Q2 2022

Aug 12, 2022

SELL
$4.02 - $5.21 $819,344 - $1.06 Million
-203,817 Reduced 79.43%
52,791 $236,000
Q1 2022

May 13, 2022

SELL
$5.0 - $9.26 $49,680 - $92,007
-9,936 Reduced 3.73%
256,608 $1.29 Million
Q4 2021

Feb 08, 2022

BUY
$7.6 - $10.26 $27,709 - $37,407
3,646 Added 1.39%
266,544 $2.32 Million
Q3 2021

Nov 15, 2021

SELL
$8.72 - $13.31 $129,561 - $197,759
-14,858 Reduced 5.35%
262,898 $2.45 Million
Q2 2021

Aug 13, 2021

BUY
$8.52 - $15.47 $2.04 Million - $3.71 Million
239,718 Added 630.21%
277,756 $3.56 Million
Q1 2021

May 12, 2021

BUY
$5.6 - $13.47 $213,012 - $512,371
38,038 New
38,038 $350,000

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.